๐ฐ Pfizer Ceo News
Pfizer Ceo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pfizer Ceo. Real-time updates on events, politics, business and more.
May 11, 2023
Reuters Editor-in-Chief Alessandra Galloni interviews Pfizer CEO Albert Bourla, a 30-year Pfizer veteran and CEO since 2019, at ...
January 20, 2023
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
January 20, 2023
Chandrashekhar shared the video of journalists confronting the Pfizer CEO, while blaming the Congress and its leaders of pushing for foreign vaccines during the pandemic.
August 15, 2022
"I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms," he said in a tweet on Monday.
April 24, 2022
Since the Wuhan coronavirus (COVID-19) was released from a lab in China, no Americans have been allowed to question the mainstream narrative that it's the deadliest pandemic to ever hit the [...]
March 18, 2022
The Victorian state government has announced an agreement with the biopharmaceutical company Pfizer to increase โglobal collaboration opportunities ...
March 15, 2022
During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus.
March 14, 2022
During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus.
March 14, 2022
During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus.
March 14, 2022
During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus.